Novartis Wins Court Fight Over Entresto Patent Listing and Generic Delay
A Manhattan federal court has sided with Novartis in a lawsuit accusing the pharmaceutical giant of using a patent listing to keep cheaper generic versions of its heart-failure drug Entresto off the U.S. market…
